MicroFluidic Systems (MFS) specializes in molecular diagnostic systems for the detection of airborne biological threats and rapid medical testing. The company, founded in 2001, focuses on homeland security and healthcare applications, and is a wholly owned subsidiary of PositiveID Corporation (OTCBB: PSID)
MFS' primary products are its M-BAND and DragonFly systems. MFS also markets a variety of assays for rapid and accurate biological detection of viruses, bacteria and other toxins.
The company's M-BAND, Microfluidics-based Bioagent Autonomous Networked Detector, runs autonomously for 30 days, continuously analyzing air samples to detect bacteria, viruses and toxins, with results in as little as two hours. Results from individual instruments are reported via a secure wireless network in real time to give an accurate and up-to-date status for instruments in the field.
The company's Dragonfly technology is a miniaturized version of M-BAND, and can be used in a healthcare setting or in the field. Dragonfly's microfluidic cartridges for biological sample processing and detection have been demonstrated effective for environmental bacteria, biothreat agents, clinical samples, antibiotic-resistant bacteria and forensic applications.
PositiveID develops innovative tools and technologies, focused on diabetes management and biological detection systems, for a better quality of life.
February 6, 2013
PositiveID Reports Issuance of Draft RFP From Dept of Homeland Security for BioWatch Generation 3
December 20, 2012
PositiveID Corporation Enters Into License Agreement and Teaming Agreement With The Boeing Company
September 28, 2012
OTC Stock Review Provides an Updated Report on PositiveID Corporation
September 24, 2012
PositiveID Corporation Comments on Department of Homeland Security's Revised Procurement Strategy for BioWatch Generation 3, Phase II